ESR1 and breast carcinoma: High ER expression in epithelial cells of hormone receptor positive breast cancer patient samples indicates cancer cells are dependent on E2 for continued growth, and targeting these cells with antiestrogens such as Tamoxifen or AIs such as Letrozole or Anastrozole will likely shrink tumors and improve patient outcome.